Immunotherapy

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

We present a prosepective study of neoadjuvant cemiplimab in high-risk resectable CSCC.

Immunotherapeutic Strategies in Skin Cancer

Primer on Immunotherapeutic Strategies in Skin Cancer

A Retrospective Study of Ipilimumab Plus Nivolumab in Anti-PD-L1/PD-1 Refractory Merkel Cell Carcinoma

We present a retrospective study of Ipi/Nivo in refractory MCC.

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

Society guidelines for the management of NMSC.

Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma

Management Pearls for Advanced CSCC

Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma

Management Pearls for Advanced CSCC

Non Melanoma Skin Cancer Immunotherapies and the Role of Dermatology Clinicians

Management Pearls for Advanced NMSC

Immunotherapy in Advanced NMSC - Treatment Selection and Collaborative Care

Pearls for the Management of Advanced NMSC

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC

Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC

Pearls for the Management of Advanced NMSC